Tenet Healthcare Reports Strong Q2 Earnings, Boosts Guidance
Shares of Tenet Healthcare (NYSE: THC) surged more than 16% on July 24 after the hospital chain reported better-than-expected second-quarter earnings and raised its full-year guidance. The company generated $5.63 billion in revenue with adjusted per-share earnings of $6.12, surpassing analyst estimates for both metrics. The positive results come amid broader concerns affecting the healthcare sector following a recent profit warning from rival HCA Healthcare due to rising numbers of uninsured patients. Tenet not only exceeded expectations but also increased its 2026 revenue forecast and adjusted EBITDA outlook, signaling strong operational performance despite industry headwinds. CEO Saum Sutaria highlighted effective execution and innovation as key drivers behind the results. Analysts had already viewed Tenet favorably before this report, with a consensus price target of $246.90 that remains above current levels even after today's gains.